Skip to content
Dompé logo — We Embrace the Challenge in Science

Dompé

We Embrace the Challenge in Science

Italy Italy 1179 employees

General Information

Company Name Dompé
Location Italy Italy
Employees 1179
Business Model B2B2C, B2B, B2C
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Dompé. To contact Dompé, visit dompe.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Dompé compare?

A PDF of Dompé and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Dompé soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 05, 2026

Dompé will participate as a premium partner in the eighth edition of il Tempo della Salute in Milan.

Key Hire Oct 27, 2026

Dompé welcomes Saverio Nucci as their new ICT Service Delivery & Operations Senior Director.

About Dompé

Dompé, a private and family-owned biopharmaceutical company, boasts over 130 years of independent history, dedicated to transforming treatments for ophthalmic, neurological, and pain conditions through groundbreaking science. This established firm has pioneered the therapeutic potential of nerve growth factor (NGF), advancing first-in-class, disease-modifying therapies that address the root causes of nerve damage rather than just alleviating symptoms.

Underpinning their success is a commitment to integrating Nobel Prize-winning science into practice, exemplified by the approval of the first topical biologic for a rare neurotrophic eye disease. Their research-driven approach combines scientific rigor with agility, underscoring their focus on developing innovative biologics and new delivery platforms to tackle difficult diseases.

Dompé's independence ensures sustained innovation and a robust integration of research, manufacturing, and commercialization. Committed to patient care and fostering scientific talent, their mission is to unleash the full potential of NGF and other molecules in reshaping nervous system treatments.

Business keywords: Biopharmaceutical, Ophthalmology, Neurology, Pain Management, Nerve Growth Factor, Disease-modifying Therapies, Topical Biologics, Neurotrophic Eye Disease, Biologics Development, Clinical Programs, Drug Delivery Platforms, Patient Support Programs, Talent Development, Scientific Innovation, Independent Pharmaceutical

Services & Products

Research and Development
Drug Manufacture
Clinical Trials
Biotech Manufacturing
Pharmaceuticals Production

Target Customers

Patients with Ophthalmic Conditions Neurological Disorders Sufferers Healthcare Providers Biotech and Pharmaceutical Stakeholders Medical Researchers

No funding data available for Dompé yet.

Dompé Alternatives & Competitors

Dompé vs
Sling Therapeutics
Sling Therapeutics United States

Focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease...

Series A
12 employees
Biopharma, Biotechnology
Dompé vs
Archimedes Pharma
Archimedes Pharma United Kingdom

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitati...

Acquired
30 employees
Biotechnology, Health Care
Dompé vs

We envision a future where people stay healthy for life

Series B
15 employees

FAQ About Dompé

We Embrace the Challenge in Science
Dompé is headquartered in Italy.
Dompé has a B2B2C, B2B and B2C business model. Its revenue comes from Product Sales and Licensing.
Dompé has approximately 1179 employees.
Dompé offers: Research and Development, Drug Manufacture, Clinical Trials, Biotech Manufacturing, Pharmaceuticals Production.
Top alternatives and competitors to Dompé include Sling Therapeutics, Archimedes Pharma, Rejuvenate Biomed, Beihai Biotech, Neurotrope Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dompé and Sling Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dompé, https://bouncewatch.com/company/dompe, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout